还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

# E; c9 ~5 [8 K& \
Sub-category:
; K9 C" A/ r7 s! |' @9 S( ]Molecular Targets
) \5 i. J, Y4 ]0 Q# {
& |7 V  N2 b/ E. M
Category:
5 e& H: n. j# ~- `Tumor Biology


Meeting:
" r2 ~5 w4 H0 G: ?( X$ h4 M2011 ASCO Annual Meeting


Session Type and Session Title:
/ L! y8 Q% N% m, uPoster Discussion Session, Tumor Biology

. Y% y2 A4 V' D4 R
Abstract No:
10517
9 e% j) x- M; U) i3 G8 f4 X. q$ B
, u" u. W1 `1 l: }/ Z
Citation:
1 I$ f0 ~: u3 ^0 ^, M( Z  @J Clin Oncol 29: 2011 (suppl; abstr 10517)

3 L4 J, t% }* j0 B. S$ Q4 F8 n
Author(s):
, }1 i; S' B; W9 |1 D, u1 p# vJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

6 S! ~9 f3 ~3 i- Y9 c- X

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
4 a2 S- Q9 s% ^) t9 e" a
4 v6 A9 T7 G. ?  R. |2 q! qAbstract Disclosures
6 q: b, q2 ]& u
: f4 X1 {! n2 a( o& _* x+ PAbstract:
% l7 J2 K8 e& ~+ C
9 R2 l& D& h, d) z! s8 W
Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.


! X! _$ }& ?& F$ q" |+ V( ?5 D: r6 Q

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

$ C6 Z* p1 m3 D. Z, k化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

/ t+ E0 W4 `: D. y8 ]4 R易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
1 p* B, G: u3 a3 `ALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
# l0 M# I  q6 t+ }. ]' Z
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊